• Home
  • Study Details
By physician referral or invitation only

RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

This is a research study to find out if antiviral or other drugs can help people who have COVID symptoms that have lasted more than 3 months after a COVID infection. This condition is known as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), including Long COVID.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Michelle Floris-Moore
Medicine-Infectious Diseases

Study Type

Clinical or Medical
Interventional

Study Topics

COVID-19

IRB Number

23-1469

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research